Accuracy of Factory-Calibrated Continuous Glucose Monitors in Critically Ill Patients Receiving Intravenous Insulin: A Prospective Clinical Trial of Two Leading Systems
Open Access
- 8 May 2025
- journal article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 20 (5) , 1585-1594
Abstract
Background: Continuous glucose monitors (CGMs) are increasingly being used to guide glucose management in the hospital. However, uncertainty regarding their accuracy in this setting remains. Methods: We conducted a nonrandomized, open-label, clinically blinded prospective trial of the Dexcom G6 Pro (G6P) and FreeStyle Libre Pro (FLP) in the inpatient setting among critically ill hospitalized patients (n = 40) requiring continuous intravenous insulin infusion. In parallel with CGM data, reference serum (Lab) glucose and point-of-care (POC) glucose values were obtained. On completion of the study, CGM and reference values were analyzed to assess CGM accuracy. Results: A total of 1015 matched G6P-Lab pairs had a mean absolute relative difference (MARD) of 22.7%, 2369 G6P-POC pairs had an MARD of 22.9%, 1006 matched FLP-Lab pairs had an MARD of 25.2%, and 2353 FLP-POC pairs had an MARD of 27.0%. Both CGM systems demonstrated considerable inter-patient variability in sensor accuracy and tended to underestimate glucose in comparison with the reference values. Rarely were low reference values overestimated by either sensor. Conclusions: Factory-calibrated continuous glucose monitors may require accuracy validation and per-patient calibration for inpatient use in critically ill patients.Keywords
Funding Information
- JDRF (5-ECR-2022-1177-A-N)
- DexCom Inc. (Investigator Initiated Study)
- National Heart, Lung, and Blood Institute (R01HL159760)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (K12DK133995)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (K23DK134880)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (P30DK020593)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (R01DK129840)
This publication has 15 references indexed in Scilit:
- Continuous Glucose Monitoring–Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical TrialDiabetes Care, 2022
- Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective StudyJournal of Diabetes Science and Technology, 2022
- Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With DiabetesDiabetes Care, 2021
- Use and Accuracy of Inpatient CGM During the COVID-19 Pandemic: An Observational Study of General Medicine and ICU PatientsJournal of Diabetes Science and Technology, 2021
- Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical TrialDiabetes Care, 2020
- Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin RegimenDiabetes Care, 2020
- Glucose homeostasis, nutrition and infections during critical illnessClinical Microbiology and Infection, 2018
- Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled TrialPediatrics, 2017
- Significance and Reliability of MARD for the Accuracy of CGM SystemsJournal of Diabetes Science and Technology, 2016
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009